WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+2.4%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$6.81B
AUM Growth
+$684M
(+11%)
Cap. Flow
+$636M
Cap. Flow
% of AUM
9.34%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
980
New
186
Increased
207
Reduced
145
Closed
238
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$129M |
| 2 |
Gilead Sciences
GILD
|
$114M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$92.7M |
| 4 |
Amazon
AMZN
|
$77.2M |
| 5 |
Analog Devices
ADI
|
$70.5M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$74.7M |
| 2 |
Palo Alto Networks
PANW
|
$59.8M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$55.4M |
| 4 |
Alkermes
ALKS
|
$55.3M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$53.9M |
Sector Composition
| 1 | Healthcare | 37.87% |
| 2 | Technology | 30.7% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 8.09% |
| 5 | Communication Services | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Gartner
IT
$18.6B
| $426K | 0.01% |
1,540
-949
| -38% | -$263K |
|
602
Sutro Biopharma
STRO
$89.9M
| $410K | 0.01% |
73,954
| – | – |
|
603
Braze
BRZE
$3.5B
| $396K | 0.01% |
+11,359
| New | +$396K |
|
604
Fabrinet
FN
$13.2B
| $392K | 0.01% |
4,106
+952
| +30% | +$90.9K |
|
|
CLLS
605
Cellectis
CLLS
$269M
| $389K | 0.01% |
+169,802
| New | +$389K |
|
|
CMCA
606
DELISTED
Capitalworks Emerging Markets Acquisition Corp Class A Ordinary Shares
CMCA
| $373K | 0.01% |
+36,898
| New | +$373K |
|
607
Knowles
KN
$1.85B
| $372K | 0.01% |
+30,566
| New | +$372K |
|
608
Axcelis
ACLS
$2.53B
| $359K | 0.01% |
5,934
-2,832
| -32% | -$171K |
|
609
Duolingo
DUOL
$12.4B
| $357K | 0.01% |
+3,749
| New | +$357K |
|
610
HilleVax
HLVX
$105M
| $344K | ﹤0.01% |
+20,108
| New | +$344K |
|
611
Sphere Entertainment
SPHR
$1.76B
| $339K | ﹤0.01% |
+7,683
| New | +$339K |
|
612
PC Connection
CNXN
$1.66B
| $324K | ﹤0.01% |
+7,181
| New | +$324K |
|
|
APCA
613
DELISTED
AP Acquisition Corp
APCA
| $304K | ﹤0.01% |
30,000
| – | – |
|
614
Carvana
CVNA
$50.9B
| $301K | ﹤0.01% |
+14,807
| New | +$301K |
|
615
Qualys
QLYS
$4.87B
| $297K | ﹤0.01% |
2,131
-3,268
| -61% | -$455K |
|
616
Tevogen Bio Holdings
TVGN
$170M
| $296K | ﹤0.01% |
29,225
+4,225
| +17% | +$42.8K |
|
|
KRON
617
DELISTED
Kronos Bio
KRON
| $295K | ﹤0.01% |
87,934
-251,439
| -74% | -$844K |
|
618
Ubiquiti
UI
$34.9B
| $294K | ﹤0.01% |
+1,000
| New | +$294K |
|
|
SAGA
619
DELISTED
Sagaliam Acquisition Corp. Class A Common Stock
SAGA
| $288K | ﹤0.01% |
+28,800
| New | +$288K |
|
|
DCT
620
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $286K | ﹤0.01% |
+24,129
| New | +$286K |
|
621
PAR Technology
PAR
$1.96B
| $280K | ﹤0.01% |
+9,477
| New | +$280K |
|
622
Nuvalent
NUVL
$5.83B
| $271K | ﹤0.01% |
+13,918
| New | +$271K |
|
623
AMC Networks
AMCX
$328M
| $269K | ﹤0.01% |
+13,274
| New | +$269K |
|
624
Roku
ROKU
$14B
| $267K | ﹤0.01% |
+4,739
| New | +$267K |
|
625
Vivid Seats
SEAT
$103M
| $263K | ﹤0.01% |
+1,716
| New | +$263K |
|